Skip to content

The Effect of mizaj based – Traditional medicine education on Sexual Dysfunction

Investigating the effect of mizaj based – Traditional medicine education on sexual dysfunction of women with type 2 diabetes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161126031117N7
Enrollment
30
Registered
2018-11-21
Start date
2018-11-22
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Abnormal glucose

Interventions

Intervention 1: Intervention group: The intervention group will receive training sessions based on their mizaj. 4 90 -minute sessions will be held at one week interval .At the end of each session, edu

Sponsors

Sari University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Women with type 2 Diabetes Age 20-55 years Marriage at least one year ago Living with partner Lack of polygamy Duration of diabetes more than 6 months and lack advanced diabetes complications (renal failure with creatinine greater than 1.5, severe autonomic neuropathy affecting sexual function, visual impairment, advanced vascular disorders HbA1C 6.5% - 8.5% Non-temporary marriage Body mass index between 20-35 kg/m2 No severe marital conflicts No smoking, no alcohol and tobacco consumption No pregnancy and lactation Lack of menopause Not using the medication effective on sexual function (antihistamines, barbiturates, amphetamines, narocotases, benzodiazepines, hallucinogens, SSRIs, antipsychotics and clomipyramines from the TCA group No hormone Therapy (estrogen and progesterone) No history of uncontrolled thyroid disorders Stroke and cardiovascular disease, cancer, acute liver failure, seizure, acute psychiatric disorder (including severe depression, severe anxiety through the questionnaire), multiple sclerosis

Exclusion criteria

Exclusion criteria: Receiving any treatment in the field of sexuality (both medicinal and non-pharmaceutical) during the study Missing more than two sessions of education Pregnancy during the study Taking medications affecting sexual function (antihistamines, barbiturates, amphetamines, Narcotics, benzodiazepines, hallucinogens, SSRIs, antipsychotics, and clomipyramines from the TCA class) During the study Hormone therapy (estrogen and progesterone) during the study

Design outcomes

Primary

MeasureTime frame
Sexual function. Timepoint: Before, immediately and eight weeks after the intervention. Method of measurement: For evaluation of sexual function, the Persian version of the Women's Sexual Function Index (FSFI) will be used.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Soghra khani

Sari University of Medical Sciences

s.khani@mazums.ac.ir+98 11 3336 8916

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026